SCHEMBL30985064

SCHEMBL30985064

Nc1ccc(N2CCN(C3CCC4(CCN(c5ccc6c(c5)C(=O)N(C5CCC(=O)NC5=O)C6O)CC4)C3)CC2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 16/20 0.42
▸ AR P10275 4/20 0.40
▸ DDB1 Q16531 5/20 0.38
▸ IKZF3 Q9UKT9 4/20 0.35
▸ TNF P01375 2/20 0.35
▸ IL1B P01584 2/20 0.35
▸ IKZF1 Q13422 2/20 0.35
▸ TBXA2R P21731 1/20 0.35
▸ IRAK1 P51617 2/20 0.34
▸ IRAK4 Q9NWZ3 2/20 0.34
▸ IRAK3 Q9Y616 2/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ HPGDS O60760 2/20 0.33
▸ CCNC P24863 1/20 0.33
▸ CDK8 P49336 1/20 0.33
▸ NTRK3 Q16288 1/20 0.33
▸ HASPIN Q8TF76 1/20 0.33
▸ CDK19 Q9BWU1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30984876 0.90 CRBN (0.42) CRBNARDDB1IKZF3ALDH1A1
SCHEMBL30985086 0.90 CRBN (0.43) CRBNARDDB1IKZF3IRAK1
SCHEMBL30985183 0.87 CRBN (0.41) CRBNARDDB1IKZF3IRAK1
SCHEMBL30985136 0.84 CRBN (0.62) CRBNARDDB1IKZF3TNF
SCHEMBL27344039 0.83 CRBN (0.50) CRBNARDDB1IKZF3TNF
SCHEMBL30984888 0.82 CRBN (0.59) CRBNDDB1IKZF3TNFIL1B
SCHEMBL27462926 0.81 CRBN (0.48) CRBNARDDB1IKZF3TNF
SCHEMBL30985002 0.81 CRBN (0.59) CRBNESR1
SCHEMBL30984870 0.81 CRBN (0.41) CRBNARDDB1IRAK1IRAK4
SCHEMBL30984987 0.79 CRBN (0.64) CRBNARDDB1IKZF3TNF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024146502-A1 WEE1 DEGRADING COMPOUNDS BEIJING NEOX BIOTECH LIMITED (CN) 2024-07-11 — — WO disclosed
Send feedback